Russia has developed a unique drug for oncological diseases called "Afotid." This became known from the materials of the Moscow 9th Arbitration Court of Appeal, which is considering appeals from the Ministry of Industry and Trade of the Russian Federation and the pharmaceutical product developer, Lina M.
"Afotid" is already being used to treat oncological diseases in volunteers. The final stage of clinical trials is only possible with this drug, which confirms its consumer value.
A drug has been developed that has no analogues in the world, allowing the treatment of oncological diseases regardless of the stage of the disease.
The safety of "Afotid" has been proven, as confirmed by the submitted documents. However, the Ministry of Industry and Trade of the Russian Federation filed a lawsuit with the arbitration court to terminate the contract with the developer, Lina M, and also demanded to recover more than 117 million rubles of unworked advance payment, a fine of 750 thousand rubles, and interest in the amount of more than 80 million rubles from the company.
Despite the legal disputes, the creation of "Afotid" opens up new horizons in the treatment of oncological diseases and emphasizes the potential of Russian pharmaceuticals in the fight against this serious problem.
Read more on this topic:
Russian researchers have synthesized an antibiotic against resistant Staphylococcus
Crabs in the service of science: biopolymers are being created from shells in Novosibirsk
